Wijziging van de Wet geneesmiddelenprijzen in verband met een aanpassing van de referentielanden

This amendment proposes changes to the Dutch Medicines Prices Act. The goal is to adjust the reference countries used for determining medicine prices within the Netherlands. This affects pharmaceutical companies and potentially the prices consumers pay for medicines. It aims to align pricing with updated international benchmarks.